| Neuroendocrine differentiation of prostate cancer: a review V Parimi, R Goyal, K Poropatich, XJ Yang American journal of clinical and experimental urology 2 (4), 273, 2014 | 319 | 2014 |
| A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer RW Ahn, F Chen, H Chen, ST Stern, JD Clogston, AK Patri, MR Raja, ... Clinical cancer research 16 (14), 3607-3617, 2010 | 132 | 2010 |
| Death induced by CD95 or CD95 ligand elimination A Hadji, P Ceppi, AE Murmann, S Brockway, A Pattanayak, B Bhinder, ... Cell reports 7 (1), 208-222, 2014 | 94 | 2014 |
| Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579) VG Kaklamani, JS Jeruss, E Hughes, K Siziopikou, KM Timms, A Gutin, ... Breast cancer research and treatment 151, 629-638, 2015 | 87 | 2015 |
| Hypoxia-inducible factor-1 α expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP AM Evens, LH Sehn, P Farinha, BP Nelson, A Raji, Y Lu, A Brakman, ... Journal of clinical oncology 28 (6), 1017, 2010 | 83 | 2010 |
| A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma In Situ of the Breast O Lee, K Page, D Ivancic, I Helenowski, V Parini, ME Sullivan, ... Clinical cancer research 20 (14), 3672-3682, 2014 | 75 | 2014 |
| Expression of nectin-4 in bladder urothelial carcinoma, in morphologic variants, and nonurothelial histotypes JH Hoffman-Censits, KA Lombardo, V Parimi, S Kamanda, W Choi, ... Applied Immunohistochemistry & Molecular Morphology 29 (8), 619-625, 2021 | 66 | 2021 |
| The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host ZS Guo, V Parimi, ME O'Malley, P Thirunavukarasu, M Sathaiah, F Austin, ... Gene therapy 17 (12), 1465-1475, 2010 | 58 | 2010 |
| Constitutive expression of a dominant-negative TGF-β type II receptor in the posterior left atrium leads to beneficial remodeling of atrial fibrillation substrate A Kunamalla, J Ng, V Parini, S Yoo, KA McGee, TT Tomson, D Gordon, ... Circulation research 119 (1), 69-82, 2016 | 52 | 2016 |
| Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor negative breast cancer MC Jun Wang, Ali Shidfar, David Ivancic, Liannian Liu, P Vamsi, ... International Journal of Cancer 140 (11), Pages 2484-2497, 2017 | 51 | 2017 |
| A Dose-Ranging Study of 0.5% Bupivacaine or Ropivacaine on the Success and Duration of the Ultrasound-Guided, Nerve-Stimulator–Assisted Sciatic Nerve Block: A Double-Blind … A Nader, MC Kendall, GS De Oliveira, L Puri, L Tureanu, A Brodskaia, ... Regional Anesthesia & Pain Medicine 38 (6), 492-502, 2013 | 50 | 2013 |
| A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia SJ Wong, B Campbell, B Massey, DP Lynch, EEW Cohen, E Blair, R Selle, ... Oral oncology 49 (9), 970-976, 2013 | 47 | 2013 |
| Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation Z Zhou, J Gao, R Popovic, K Wolniak, V Parimi, JN Winter, JD Licht, ... Leukemia & lymphoma 56 (10), 2895-2901, 2015 | 41 | 2015 |
| Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib VG Kaklamani, K Siziopikou, D Scholtens, M Lacouture, J Gordon, R Uthe, ... Breast cancer research and treatment 132, 833-842, 2012 | 39 | 2012 |
| Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells E Tarasewicz, L Rivas, R Hamdan, D Dokic, V Parimi, BP Bernabe, ... Cell Cycle 13 (20), 3191-3201, 2014 | 38 | 2014 |
| Lung transplantation in patients 60 years and older: Results, complications, and outcomes PW Smith, H Wang, V Parini, JS Zolak, KR Shen, TM Daniel, MK Robbins, ... The Annals of thoracic surgery 82 (5), 1835-1841, 2006 | 38 | 2006 |
| c-Met overexpression in cervical cancer, a prognostic factor and a potential molecular therapeutic target T Refaat, ED Donnelly, S Sachdev, V Parimi, MD Samar El Achy, P Dalal, ... American Journal of Clinical Oncology 40 (6), 590-597, 2017 | 32 | 2017 |
| CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin E Tarasewicz, R Hamdan, J Straehla, A Hardy, O Nunez, S Zelivianski, ... Cancer biology & therapy 15 (10), 1301-1311, 2014 | 30 | 2014 |
| Stable luciferase expression does not alter immunologic or in vivo growth properties of GL261 murine glioma cells AJ Clark, M Safaee, T Oh, ME Ivan, V Parimi, R Hashizume, T Ozawa, ... Journal of translational medicine 12, 1-8, 2014 | 29 | 2014 |
| A mother and daughter with phyllodes tumors of the breast CE Foucar, A Hardy, KP Siziopikou, L Wang, V Parini, N Hansen, ... Clinical breast cancer 12 (5), 373-377, 2012 | 22 | 2012 |
XIMING YANGNorthwestern University Feinberg School of MedicineVerified email at northwestern.edu
